Back
New Oriental Education & Technology Group, Inc. Vs. Novartis AG Industry Stock Comparison
Sell
42
EDU
New Oriental Education & Technology Group, Inc.
Last Price:
$55.82
Seasonality Move:
4.45%
Buy
70
NVSEF
Novartis AG
Last Price:
$138.48
Seasonality Move:
0.17%
Sell
42
New Oriental Education & Technology Group, Inc. (EDU)
is a Sell
Is New Oriental Education & Technology Group, Inc. a Buy, Sell or Hold?
-
The current New Oriental Education & Technology Group, Inc. [EDU] share price is $55.39. The Score for EDU is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
EDU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $138.48. The Score for NVSEF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EDU Stock Price Chart
What is New Oriental Education & Technology Group, Inc.'s stock price today?
-
The New Oriental Education & Technology Group, Inc. share price today is $55.39The current trend is moderately bullish and EDU is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $138.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
EDU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 56.1 | Buy |
| Chaikin Money Flow: | 356020 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.68 - 55.38) | Buy |
| Bollinger Bands (100): | (49.13 - 56.61) | Buy |
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.52 | Buy |
| Relative Strength Index (14 RSI): | 63.5 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (125.84 - 134.48) | Buy |
| Bollinger Bands (100): | (121.49 - 131.91) | Buy |
EDU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.62 | Sell |
| 20-day SMA: | 54.15 | Buy |
| 50-day SMA: | 55.13 | Buy |
| 200-day SMA: | 50.47 | Buy |
| 8-day EMA: | 55.41 | Sell |
| 20-day EMA: | 54.65 | Buy |
| 50-day EMA: | 54.13 | Buy |
| 200-day EMA: | 53.31 | Buy |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 133.82 | Buy |
| 20-day SMA: | 130.37 | Buy |
| 50-day SMA: | 128.64 | Buy |
| 200-day SMA: | 119.87 | Buy |
| 8-day EMA: | 134.97 | Buy |
| 20-day EMA: | 131.83 | Buy |
| 50-day EMA: | 129.17 | Buy |
| 200-day EMA: | 121.31 | Buy |
New Oriental Education & Technology Group, Inc. Earnings Growth & EDU Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.62 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
New Oriental Education & Technology Group, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novartis AG Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||